Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Levine Cancer Institute
1021 Morehead Medical Dr
Charlotte, NC 28204- Is this information wrong?
Summary
- Lymphoma expert specializing in Hodgkin lymphoma, Non-Hodgkin lymphoma, and Chronic lymphocytic leukemia.
Clinical Expertise
- Non-Hodgkin lymphoma, Hodgkin's lymphoma, Hematologic oncology, Lymphoma
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2005 - 2009
- University of Washington School of MedicineFellowship, Oncology/Bmt, 2005 - 2009
- University of WashingtonResidency, Internal Medicine, 2002 - 2005
- University of California, Davis, School of MedicineClass of 2002
- University of California, BerkeleyBA
Certifications & Licensure
- NC State Medical License 2009 - 2025
- WA State Medical License 2005 - 2011
Clinical Trials
- Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma Start of enrollment: 2011 Mar 01
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
- Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma Start of enrollment: 2012 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Genetic Predictors of Ibrutinib-related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia.Issam S Hamadeh, Jai N Patel, Ryan Jacobs, Hang Zeng, Jiaxian He, Bei Hu, Tamara Kay Moyo, Amy Soni, Steven Park, Ed Copelan, Belinda Avalos, Alicia Hamilton, Nury Ste...> ;Clinical Cancer Research. 2023 Dec 1
- 3 citationsImpact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie S Grover, Stephanie Mathews, Made...> ;Blood Advances. 2023 Jun 13
- 7 citationsCombination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Results from a Phase 1b Study.M Lia Palomba, Brian G Till, Steven I Park, Franck Morschhauser, Guillaume Cartron, Reinhard Marks, Mahesh Shivhare, Wan-Jen Hong, Aparna Raval, Alice C Chang, Elicia ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Jul 1
- Join now to see all
Abstracts/Posters
- Outcomes Following Early Relapse in Patients with Mantle Cell LymphomaSteven I Park, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally ManagedSteven I Park, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Monotherapy Activity with the First CD20-Targeted Immunotoxin, MT-3724, in Subjects with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)Steven I Park, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- Follicular LymphomaSeptember 20th, 2023
- Next Gen InnovatorMarch 19th, 2021
- Brentuximab vedotin shows promise in Hodgkin lymphomaDecember 2nd, 2021
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
- Atrium Health's Carolinas Medical CenterCharlotte, North Carolina
- Wake Forest Baptist Medical CenterWinston Salem, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: